GoodRx Holdings reports mixed Q3 earnings; initiates Q4 and FY23 outlook (NASDAQ:GDRX)

$ in thousands and thousands

4Q 2023

4Q 2022

YoY Change

Income^{5 vs. consensus of $192.67M}

$188-$194

$184.1

2%-5%

Adjusted Income⁵

$188-$194

$184.1

2%-5%

Adjusted EBITDA Margin⁶

Mid-to-high twenty-percent vary

$ in thousands and thousands

FY 2023

FY 2022

YoY Change

Income^{5 vs. consensus of $754.94M}

$742-$748

$766.6

(3%)-(2%)

Adjusted Income⁵

$752-$758

$766.6

(2%)-(1%)

Adjusted EBITDA Margin⁶

Excessive twenty-percent vary